title: Cellular adaptive immune system plays a crucial role in trastuzumab clinical efficacy.
authors.forename: Filippo
authors.initials: F
authors.lastname: Bellati
authors.forename: Chiara
authors.initials: C
authors.lastname: Napoletano
authors.forename: Ilary
authors.initials: I
authors.lastname: Ruscito
authors.forename: Marco
authors.initials: M
authors.lastname: Liberati
authors.forename: Pierluigi Benedetti
authors.initials: PB
authors.lastname: Panici
authors.forename: Marianna
authors.initials: M
authors.lastname: Nuti
mesh_terms: D056704:Adaptive Immunity; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab; C508053:ERBB2 protein, human